Cite
HARVARD Citation
Hershfield, M. et al. (n.d.). FRI0372 Pharmacokinetics and immunogenicity of pegloticase (PL) infused every 3 weeks to treat refractory gout (RG), including in organ transplant recipients (TR). Annals of the rheumatic diseases. p. 440. [Online].